Tim Demuth - 01 Aug 2021 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PVLA)

Role
Chief Medical Officer
Signature
/s/ Megan Gates, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
01 Aug 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 16:19:13 UTC
Next filing
24 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIRS Stock Option (right to buy) Award $0 +360,000 $0.000000 360,000 01 Aug 2021 Common Stock 360,000 $3.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the option shares on August 1, 2022 and vests as to an additional 6.25% of the option shares at the end of each successive calendar quarter thereafter beginning on December 31, 2022.